Oct. 19, 2017:
As the Big Ten CRC leads the rapidly-changing world of cancer research, Across the Consortium is your one-stop source for the latest. From technologies to funding, and from public health to discoveries we hand-pick the breaking stories so you don’t miss a thing!
Oct. 19, 2017: Researchers and leaders from 12 Big Ten cancer centers will meet at Big Ten Conference Headquarters in Chicago on Saturday. The Big Ten Cancer Research Consortium Summit is expected to draw about 150 participants, including researchers from across the consortium and representatives from pharmaceutical and biotech companies. The University of Illinois Cancer Center and the Robert H. Lurie Comprehensive Cancer Center of Northwestern University are co-hosting the meeting. Read More
Oct. 1, 2017: Investigator Spotlight Hamid Band, MD, PhD, Fred & Pamela Buffett Cancer Center Educational background: M.D. Medical College, Srinagar,, Kashmir University, India; Ph.D. Immunology, All-India Insitute of Medical Sciences, New Delhi, India Research interests: Our research focuses on two major topics, both geared to understand, and potentially target, the intracellular traffic of cell surface receptors coupled to activation of tyrosine kinase signaling: the CBL-family of ubiquitin ligases, which provides an essential mechanism of negative regulation of receptor and non-receptor tyrosine kinases through ubiquitin-dependent proteasomal and lysosomal degradation; and members of the EHD family...
Sept. 25, 2017: The Big Ten Cancer Research Consortium (Big Ten CRC) announces the opening of a clinical trial for patients with advanced or recurrent endometrial cancer. The study, known as BTCRC-GYN15-013, involves pembrolizumab, one of a new class of drugs called PD-1 inhibitors, given in combination with routine care using paclitaxel and carboplatin chemotherapy. The Robert H. Lurie Comprehensive Cancer Center of Northwestern University in Chicago is currently enrolling subjects in this study. Additional member sites within the Big Ten Cancer Research Consortium will open the trial in the coming months. Read More
Sept. 20, 2017: Each month, the Big Ten Cancer Research Consortium highlights advances in research and treatment led by our member institutions. Following are recent developments from Across the Consortium: Read More
Aug. 26, 2017: The Big Ten Cancer Research Consortium‘s Across the Consortium is your front row seat to the latest in Big Ten CRC news. This month we highlight new discoveries from our member institutions, celebrate awards, and feature outstanding researchers as well as volunteers from across the consortium. Read More
Aug. 2, 2017: Investigator Spotlight Barbara Pro, MD, Robert H. Lurie Comprehensive Cancer Center of Northwestern University Educational background: MD, University La Sapienza in Rome Italy; Residency: Mount Sinai Hospital, New York Research interests: Dr Pro’s research focus has been on the development of new therapies for the management of patients with Hodgkin lymphoma and non-Hodgkin lymphoma. She has served as the PI on numerous clinical trials, including three trials that led to the approval of novel agents for the treatment of T-cell lymphomas. Dr. Pro is an internationally renowned clinician and researcher and her work has been published extensively. Little-known facts about...
July 20, 2017: Did you hear the latest news from across the Big Ten Cancer Research Consortium? While it may seem impossible to keep pace with the member institutions in their fight against cancer, you do not have to miss the action. From historic moments, to monumental studies, to game-changing discoveries, you can celebrate the latest wins every time you tune in for another monthly edition of Across the Consortium! Read More
July 16, 2017: The Indiana University Melvin and Bren Simon Cancer Center hosted Doug Lowy, the acting director of the National Cancer Institute, for a full-day visit on June 28. (Photo: Drs. Schneider (left) and Milan Radovich (middle) explain their work on the next generation of personalized medicine with Dr. Doug Lowy, acting director of the National Cancer Institute. Dr. Lowy visited the IU Simon Cancer Center on June 28. Photo credit: IU Simon Cancer Center) In a series of small-group discussions in the morning, he met with cancer center members (members' names appear in bold) and others to learn about: Pediatric genomics with D. Wade...
June 20, 2017: Summer is officially here and so is the hottest news in cancer research - at your fingertips in this month's edition of Across the Consortium. Get up to date on the latest discoveries, game-changing breakthroughs, and big-time funding achievements. Don't miss the inspirational moments that go down in history, from the dedication of the "Search" Tower to a discussion with family of Henrietta Lacks - source of the HeLa cell line. All this and more as we take you Across the Consortium! Read More
University of Illinois
Indiana University
University of Iowa
University of Maryland
University of Michigan
Michigan State
University of Minnesota
University of Nebraska
Northwestern University
Penn State University
Purdue University
Rutgers State University
University of Wisconsin
University of Illinois at Chicago
© 2024 All rights reserved.
Big Ten Cancer Research Consortium
7676 Interactive Way, Suite 120, Indianapolis, IN 46278
Subscribe to the Big Ten CRC Newsletter
X
Facebook
YouTube